The IL-2 system which involves IL-2 production, IL-2 receptor expression, and response to IL-2, is associated with autoimmune phenomena. Immunological abnormalities including autoimmune phenomena are believed to contribute to the pathogenesis of IDDM. In this study, the production of IL-2, the responses to IL-2 and IL-2 receptor expression by peripheral blood T lymphocytes were compared in IDDM and normal non-diabetic children. The percentage of IL-2 receptorpositive circulating T cells was significantly increased in diabetic children, although IL-2 receptor expression induced by con A stimulation did not differ in the diabetic and control children. IL-2 production was significantly decreased in diabetic children compared with the control children. The response of stimulated T cells to IL-2 did not differ in IDDM and control children. In IDDM, IL-2 production by CD4-positive T lymphocytes within the IL-2 system is thought to be selectively defective. On the other hand, IL-4, which is also produced by CD4-positive T lymphocytes, was increased. Since IL-4 did not suppress IL-2 production, it would seem that the IL-2 producing subset in CD4+HLA-DR + T cells is decreased in IDDM. These results suggest that in recent onset IDDM, IL-2 receptor-positive circulating T cells require an IL-2 supply. [Diabetologia (1994) 37: 476-482] Key words IDDM, interleukin 2 system, interleukin 4, T helper 1 and 2
now believed to contribute to the pathogenesis of IDDM, regardless of factors related to ethnic differences. The presence of immunological abnormalities involving autoimmune phenomena in IDDM suggests that T lymphocytes might play an important role in the pathogenesis of this disease [7] .
The IL-2 system, which includes IL-2 production, IL-2 receptor expression, and response to IL-2, plays an essential role in T cell proliferation [8] and differentiation [9, 10] . We therefore measured these parameters of the IL-2 system to determine whether the immunological abnormalities associated with IDDM were related to the function of this system. It has been reported [11, 12] that IL-2 synthesis is decreased in patients with IDDM: IL-2 receptor expression and response to IL-2 have not, however, been studied in these patients. We therefore made simultaneous measurements of these parameters in IDDM children and compared them with results obtained from normal nondiabetic children. The mechanisms responsible for the suppression of IL-2 production have also been considered.
Subjects and methods

Subjects
Thirty-seven Japanese IDDM children (22 females, 15 males, aged 3 to 18years, mean ll.7years) and 37 age-and sexmatched healthy Japanese children (22 females, 15 males, aged 4 to 16, mean 11.2 years) were enrolled in this study. All patients had the classic symptoms and history of IDDM: acute onset, lack of obesity, and an absolute requirement for exogenous insulin. No other clinically evident autoimmune disease was present in the study subjects. The IDDM children were divided into four groups according to the duration of disease: up to 1 year (n = 12), 1 to 3 years (n = 7), 3 to 5 years (n = 6), and more than 5 years (n = 12). Twelve of these children were ICA-positive; 8 of them were newly diagnosed (within 1 year) with IDDM. Informed consent was given by the parents of all subjects and the study was approved by the hospital ethics committee.
Cell separation
PMNC were separated from heparinized venous blood by FicollIsopaque (Pharmacia, Uppsala, Sweden) density gradient centrifugation.
Lymphocyte subsets
The cells were stained with monoclonal antibodies using standard immunofluorescence procedures. For single-colour analysis, the antibodies used were labelled with fluorescein, and for twocolour analysis they were labelled with fluorescein or phycoerythrin. T cell subsets were identified with the monoclonal antibodies, CD3, CD4, CD8 (OKT3, OKT4, OKT8: Ortho, Raritan, NJ, USA), CD25 (anti-IL-2 receptor), and HLA-DR (BectonDickinson, Sunnyvale, Calif., USA). Lymphocyte subsets were quantified by flow cytometry (JASCO FCM-1D cell sorter, Japan Spectroscopic Co. Ltd., Tokyo, Japan). The background fluorescence profile was subtracted from each sample. For each analysis, we used 2 x 105 cells.
To induce IL-2 receptors, PMNC, at a final concentration of 1 x 10 6 lymphocytes/ml in RPMI 1640 culture medium supplemented with 10 % fetal calf serum, were stimulated with various concentrations of con A (E.Y. Laboratory, San Marco, Calif., USA) in 5 % CO2 at 37*C. Following stimulation, the presence of IL-2 receptors was tested for as described above, using the CD25 monoclonal antibody.
IL-2 and IFN-7 production
PMNC were cultured as described above for IL-2 receptor induction in the presence of 5 p.g/ml con A. After 24 h, the supernatant was removed and assayed for IL-2 production, and the cells were prepared for testing the response to IL-2. The quantity of IL-2 produced by con A-stimulated lymt~hocytes was determined by measuring the ability to induce [6-~H]-thymidine (specific activity 19.3 Ci/nmol: New England Nuclear, Boston, Mass., USA) uptake in murine IL-2-dependent T lymphocytes [13] . Long-term cultured IL-2-dependent cells were a gift of Shionogi Company (Osaka, Japan). To confirm production of the IL-2 molecule, an ELISA (Genzyme Co., Boston, Mass., USA) was also performed; this was done according to the manufacturer's instructions, except in the case of standard IL-2 (same r-IL-2 used in bioassay). Units of IL-2 activity were determined using recombinant human IL-2 (r-IL-2: Shionogi Co.) as a standard. IFN-y in the same specimen, was also measured with an ELISA (Genzyme Co.).
Response to IL-2
The cultured cells described above were washed three times with phosphate-buffered saline supplemented with 10mg/ml ctmethyl-o-mannoside (Sigma, St. Louis, Mo., USA) and cultured at a final concentration of 5 • 105 lymphocytes/ml, in RPMI 1640 culture medium supplemented with 10 % fetal calf serum and 10 mg/ml tx-methyl-D-mannoside, with or without r-IL-2. At the times indicated, 12.5 ~Ci/ml of [6-3H]-thymidine was added, and the amount of radioactivity incorporated into the cells was deter- 
IL-4 production
PMNC were cultured as described above for IL-2 receptor induction in the presence of 5 pg/ml con A. After 24 h, the supernatant was removed to be assessed for IL-4 production by ELISA (Genzyme Co.). Serum IL-4 was also measured by ELISA (Genzyme Co.).
Effect of r-IL-4 on IL-2 production
PMNC from healthy control and IDDM children were cultured with various concentrations of human recombinant IL-4 (r-IL-4: Genzyme Co.) as described for IL-2 receptor induction in the presence of 5 pg/ml con A. After 24 h, the supernatant was removed to be assayed for IL-2 production by ELISA, and the cells were prepared for the RNA blot analysis.
RNA blot hybridization
Total cellular RNA was extracted from con A-stimulated PMNC by a guanidinium isothiocyanate/cesium chloride ultracentrifugation method [14] . The RNA was denatured and separated on 0.8 % agarose/formaldehyde gel [15] . RNA was then transferred onto a nylon filter and hybridized with a 32p_ labelled 0.6-kb PstI fragment of the cDNA clone p3-16 from human IL-2 [16] (a gift from Dr. T. Taniguchi, Institute for Molecular and Cellular Biology, Osaka University, Osaka, Japan) and the third exon of human fl-actin [17] (a gift from Dr. T. Noguchi, Department of Nutrition, Medical School, Osaka University) under conditions described previously [18] . The filter was exposed to Kodak XAR-5 film at -70"C with an intensifying screen for 15 h for IL-2 testing and 5 h for fl-actin testing. The band intensity was quantified using a Shimazu (Tokyo) dualwavelength TLC scanner, model CS-930.
Statistical analysis
Results are given as mean + SD. The significance of differences between group means was determined using Student's t-test. p values of less than 0.05 were considered significant.
Results
Surface marker analysis
The proportions of T cell subsets, defined as the percentage of lymphocytes stained with CD3, CD4, and CDS, respectively, were not different for IDDM and normal control children. However, the percentages of IL-2 receptor and HLA-DR-positive activated T cells was significantly higher (p < 0.001) in IDDM children than in the controls ( Table 1 ). The activated T cells, as assessed by two-colour analysis, were mostly CD4-positive, and in the group in which the duration of the were significantly increased compared to the other diabetic groups in which the duration of the disease was more than 1 year (Fig. 1) . IL-2 receptor expression induced by con A stimulation was also studied. To determine the proper experimental conditions, we performed dose-response and time course experiments with con A ( Table 2 ). As summarized in Table 2 , the incidence of IL-2 receptor expression was similar for the control and IDDM patients. A dose of 5 Izg/ml con A caused a marked increase in the number of IL-2 receptor-positive cells. However, at concentrations of 7.5 I.tg/ml or higher, con A did not enhance IL-2 receptor expression. Receptor expression increased through the initial 48 h of incubation. Thus, we selected the 5 Ixg/ml concentration of con A and a 48-h incubation period for stimulation.
There was no difference between IDDM and control children in IL-2 receptor expression induced by con A stimulation (Fig. 2) .
IL-2 and IFN-7 production
Since bioassays for IL-2 can be affected by the presence of synergistically acting cytokines or inhibitory components or both, we measured both the activity and the quantity of IL-2. IL-2 production was significantly and consistently less (p < 0.001) in IDDM children than in control children: especially in those children in whom the duration of disease was less than I year (Fig.3) . There was a close correlation between the results of the bioassay and those of ELISA (r = 0.826,p < 0.001; data not shown). We also tested the gene expression associated with IL-2, and demonstrated a decrease in IL-2 m R N A associated with IDDM (Fig. 4) . In IL-2 production, there were no significant differences either between well controlled (Hb Ale < 8 %) and poorly controlled ( H b A l c > 8 % ) IDDM children or between HLA types (data not shown). IFN-7 production showed the same pattern as IL-2 production (IDDM children, 7.2 + 3.2 U/ml vs control children, 15.0 + 6.2 U/ml;p < 0.001).
IL-4 production
It has been suggested that the production of IL-2 is closely related to that of IL-4. We therefore studied IL-4 production by PMNC in both IDDM and control children. Although there was no difference in IL-4 levels between the IDDM and normal control children, IL-4 production stimulated by con A was significantly increased in IDDM (p < 0.001) (Fig. 5) .
Effect of lL-4 on IL-2 production
To clarify whether IL-4 affected IL-2 synthesis, we studied the effect of r-IL-4 on the IL-2 production induced by con A stimulation. IL-4 did not suppress this IL-2 production (Fig. 6 ).
Response to IL-2
The response of stimulated T lymphocytes to IL-2 was also studied. To determine the IL-2 concentration to be used, we performed dose-response experiments ( Table 3) . As the concentration of IL-2 was increased to 25 U/ml, T lymphocyte proliferation was observed; T. Tomoda et al.: IL-2 system in IDDM Proliferative ability of PMNC from healthy control (n = 8) and IDDM (n = 8) children in the presence of indicated doses of exgenous r-IL-2 for 48 h. The results are expressed 10-3 cpm. Each value represents the mean + SD from four different preparations however, at concentrations above 25 U/ml, proliferation plateaued. We therefore used a concentration of 25 U/ml IL-2 in the subsequent studies. The response to IL-2 of stimulated T lymphocytes from IDDM children did not differ from that of control T lymphocytes (Fig.7) . In IDDM, there was a close correlation between the response to IL-2 and the IL-2 receptor expression induced by con A stimulation (r = 0.513,p < 0.01). IDDM children (n = 37). 5 x l12/ml PMNC were cultured with or without 25 U/ml r-IL-2 for 48 h. Response to IL-2 is expressed as thymidine uptake (cpm x 10-3). Vertical lines and bars are means + SD
Discussion
During activation, T cells synthesize and secrete IL-2 and express IL-2 receptors. IL-2 binds its receptor, and consequently exerts proliferative effects on activated T cells [14] . IL-2 also contributes to the abrogation of suppressor cell function [9] and to the promotion of helper cell function [10, 19] . All of these functions have been found to be altered in patients with systemic lupus erythematosis [20] . Furthermore, studies of the mouse strains MRL/lpr and BXSB, which are animal models of lupus erythematosis, have demonstrated that the synthesis of IL-2 is decreased in these animals compared to that in unaffected strains [21, 22] . These findings suggest that the response to and/or production of IL-2 may be associated with the presence of autoimmune disease. Non-obese diabetic mice, similar to other autoimmune mouse strains, produced small amounts of IL-2, and responded poorly in a syngenic mixed lymphocyte reaction [23] . We therefore studied IL-2 system parameters to determine whether immunological abnormalities and autoimmune phenomena were associated with IDDM. Although the number of CD4 § T cells in IDDM children did not differ from that in control children, activated CD4 + T cells in the diabetic children were significantly higher than in the control children. IL-2 synthesis was significantly less in diabetic children, as had been described in previous reports [11, 12] . Regarding the defective production of IL-2, IL-2 is consumed in abnormal quantities in the presence of high levels of low affinity IL-2 receptors [24, 25] . However, we found that T lymphocytes in IDDM proliferated in response to r-IL-2 in a concentration-dependent manner at concentrations of less than 25 U/ml, and there was a close correlation be-tween the response to IL-2 and the IL-2 receptor expression induced by con A stimulation. The induced IL-2 receptor therefore seemed to be a high affinity receptor. There was no significant difference between diabetic children and normal control children in con Ainduced IL-2 receptor expression or response to IL-2. These results suggested that IL-2 receptors contributed to the IL-2-driven proliferation of T cells, but that IL-2 production required another signal. Regarding IL-2 system function in IDDM, it is thought that IL-2 production is selectively defective. To clarify the nature of the defect in the level of IL-2 production, we studied IL-2 mRNA, protein and activity. IL-2 mRNA production was found to be lower in IDDM children than in control children. It has been possible, in mice, to identify two functionally distinct subsets of MHC class II-restricted CD4 + helper/inducer T cells, on the basis of IL gene transcription and secretion [26] [27] [28] . The Thl subset secretes IL-2 and IFN-Tupon stimulation, while, in contrast, the Th2 subset secretes IL-4 and IL-5. We hypothesized that a change in the proportion of the Thl and Th2 subsets of CD4 § + T cells was associated with IDDM, or that the overproduction of IL-4 suppressed IL-2 production in diabetic patients [29] . We therefore determined IL-4 production by PMNC with and without con A stimulation for both IDDM and control children, and found that a high level of IL-4 was present in diabetic patients. Furthermore, IL-4 did not suppress the IL-2 and IFN-),production induced by con A stimulation. Thus, it seemed that the IL-2-producing T cell subset in IDDM was selectively defective. Recently, Rapoport et al. [30] reported that exogenous rlL-4 reversed T cell function in non-obese diabetic mice in vitro and protected against diabetes in vivo. These experiments were performed in the prediabetic stage in an animal model that develops fatal IDDM. Although IDDM in humans and in this model results from T cell-mediated autoimmunity against pancreatic insulin-producing beta cells, the development of the autoimmune state may differ. Although the expression of IL-2 receptors on peripheral T lymphocytes was significantly greater in diabetic than in control children, the sensitivity of T cell IL-2 receptor expression to con A stimulation was similar in the diabetic children and the normal controls. Zielasec et al. [31] reported that administration of IL-2 suppressed the development of diabetes in the high incidence BB rat. The expression of IL-2 receptors on circulating T cells seems to required the IL-2 supply, especially in recent onset IDDM children.
